Aspargo Laboratories
Dr. Steven Kaplan is Director of the Men’s Wellness Program, Mount Sinai Health System and Professor, Icahn School
of Medicine at Mount Sinai.
Dr. Kaplan is a Diplomat of the American Board of Urology and a Fellow of the American College of Surgeons. He is
an internationally recognized authority and one of the primary thought leaders in the study of benign diseases of the
prostate, the association of metabolic factors and voiding dysfunction, and female urology. He has over 1000
publications including 600 peer-reviewed articles and 90 book chapters. His landmark study, published in JAMA in
2006, changed the way medications are used in the treatment of men with symptoms related to both benign prostate
enlargement and bladder dysfunction. He has made over 340 presentations in more than 35 countries. He is the co-
author of five books and is on the Editorial Board of numerous journals including Urology, Journal of Urology, and
Urology Times.
Dr. Kaplan is a member of more than 30 professional organizations, has been awarded 5 NIH grants, and has received
over 13 million dollars in research funding. He serves as both member and/or Chair of numerous study sections for
the NIH and more recently, he chaired the NIDDK Prostate Strategic Planning Committee and currently Chairs the
AUA Research Committee on Advocacy. He also has served on the American Urologic Association Guidelines Panel
for BPH. He was awarded the John K. Lattimer Award for Lifetime Achievement in Urology by the National Kidney
Foundation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Aspargo Laboratories
Aspargo Laboratories, Inc. is a clinical-stage biopharmaceutical company developing patient-focused solutions and must-have medicines by combining their innovative science and technologies and FDA’s 505(b)(2) approval pathway to enhance currently marketed drugs with well-known pharmacology profiles.